UNII B769I4XPY3

ADENO-ASSOCIATED VIRUS

UNII Information

Unique Ingredient Identifier: B769I4XPY3
The Unique Ingredient Identifier (UNII) is a unique alphanumeric code assigned to a specific substance or ingredient by the FDA (Food and Drug Administration). UNII codes are non-proprietary, free, unique, unambiguous and nonsemantic. Each UNII code consists of 10 characters with both letters and numbers. The first two characters represent the source of the substance while the remaining eight characters represent the specific substance. UNII codes are primarily used to identify and track substances in several drug databases and regulatory documents related to drugs, biologics, and medical devices.
Preferred Substance Name: ADENO-ASSOCIATED VIRUS
The Preferred Substance Name (PSN) is the official or preferred name of a substance or ingredient. The preferred name provides a standardized and consistent name for each substance is used in the UNII code system. The preferred name may differ from other names also commonly used to refer the same substance. The PSN is usually the name used by regulatory agencies like the FDA.
Substance Type: INGREDIENT SUBSTANCE
The International Organization for Standardization - ISO 11238 substance type is used as a data element in the UNII code system to provide additional information about the type of substance being identified.

UNII Synonyms and Mappings

The following synonyms and mappings provide alternative ways to refer to the same substance or ingredient. Synonyms may include different names or spellings, alternate chemical names, trade names, or other common names.

  • AAV - Common Name
  • ADENO-ASSOCIATED VIRUS - Common Name

UNII Resources

Inxight Drugs
The National Center for Advancing Translational Sciences (NCATS) Inxight Drugs database has a comprehensive drug development information. The NCATS Inxight Drugs includes manually curated data provided by private companies and FDA. The database has marketing and regulatory status information, rigorous drug ingredient definitions, biological activity, clinical use, etc.
DailyMed Regulated Products
The National Library of Medicine DailyMed is a searchable database that includes the most recent product labeling information submitted to the FDA by private companies.
NCATS GSRS Full Record
The Global Substance Registration System (GSRS) was designed to facilitate global monitoring of human and animal medicinal, food, tobacco, and cosmetic products. GSRS includes unique substance identifiers consistent with the ISO 11238 standard.

UNII Crossover to NDC Codes

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
71894-120Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-121Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-122Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-123Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-124Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-125Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-126Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-127Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-128Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-129Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-130Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-131Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-132Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-133Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-134Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-135Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-136Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-137Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-138Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-139Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-140Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-141Proprietary Name: Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE